Hogy Medical Co.,Ltd. (HGYMF)
USD 24.34
(0.0%)
USD 24.34
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 13.91 Billion JPY | 9899.14% |
| 2023 | 139.24 Million JPY | -10.64% |
| 2022 | 155.82 Million JPY | 77.67% |
| 2021 | 87.7 Million JPY | -25.68% |
| 2020 | 118 Million JPY | 9.58% |
| 2019 | 107.68 Million JPY | -5.26% |
| 2018 | 113.66 Million JPY | -6.62% |
| 2017 | 121.71 Million JPY | 10.75% |
| 2016 | 109.9 Million JPY | -99.44% |
| 2015 | 19.64 Billion JPY | 30.68% |
| 2014 | 15.03 Billion JPY | 73.22% |
| 2013 | 8.67 Billion JPY | 1.99% |
| 2012 | 8.5 Billion JPY | -6.86% |
| 2011 | 9.13 Billion JPY | -6.33% |
| 2010 | 9.75 Billion JPY | -6.54% |
| 2009 | 10.43 Billion JPY | -12.18% |
| 2008 | 11.88 Billion JPY | 6.1% |
| 2007 | 11.2 Billion JPY | 30.9% |
| 2006 | 8.55 Billion JPY | -49.39% |
| 2005 | 16.9 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 13.91 Billion JPY | 9896.27% |
| 2024 Q1 | 109.84 Million JPY | -21.11% |
| 2024 Q2 | 101.91 Million JPY | -7.21% |
| 2024 Q4 | 13.91 Billion JPY | 13966.89% |
| 2024 Q3 | 98.94 Million JPY | -2.91% |
| 2023 Q3 | 130.44 Million JPY | 6.7% |
| 2023 FY | 139.24 Million JPY | -10.64% |
| 2023 Q4 | 139.24 Million JPY | 6.74% |
| 2023 Q1 | 134.74 Million JPY | -13.53% |
| 2023 Q2 | 122.26 Million JPY | -9.27% |
| 2022 Q4 | 155.82 Million JPY | 105.19% |
| 2022 FY | 155.82 Million JPY | 77.67% |
| 2022 Q3 | 75.94 Million JPY | -22.6% |
| 2022 Q1 | 85.69 Million JPY | -99.12% |
| 2022 Q2 | 98.11 Million JPY | 14.5% |
| 2021 Q2 | 10.28 Billion JPY | -6.06% |
| 2021 Q4 | 9.69 Billion JPY | 7.47% |
| 2021 Q3 | 9.01 Billion JPY | -12.34% |
| 2021 FY | 87.7 Million JPY | -25.68% |
| 2021 Q1 | 10.95 Billion JPY | -14.05% |
| 2020 Q4 | 12.74 Billion JPY | 28.65% |
| 2020 Q1 | 13.71 Billion JPY | 14.99% |
| 2020 FY | 118 Million JPY | 9.58% |
| 2020 Q2 | 12.8 Billion JPY | -6.62% |
| 2020 Q3 | 9.9 Billion JPY | -22.63% |
| 2019 Q4 | 11.92 Billion JPY | 17.8% |
| 2019 Q2 | 11.45 Billion JPY | 2.91% |
| 2019 Q1 | 11.13 Billion JPY | -7.92% |
| 2019 Q3 | 10.12 Billion JPY | -11.65% |
| 2019 FY | 107.68 Million JPY | -5.26% |
| 2018 Q3 | 11.37 Billion JPY | -11.41% |
| 2018 Q1 | 12.64 Billion JPY | -6.79% |
| 2018 FY | 113.66 Million JPY | -6.62% |
| 2018 Q4 | 12.09 Billion JPY | 6.29% |
| 2018 Q2 | 12.84 Billion JPY | 1.53% |
| 2017 Q3 | 11.31 Billion JPY | -9.91% |
| 2017 Q2 | 12.55 Billion JPY | -12.27% |
| 2017 Q1 | 14.31 Billion JPY | 15.88% |
| 2017 FY | 121.71 Million JPY | 10.75% |
| 2017 Q4 | 13.56 Billion JPY | 19.91% |
| 2016 Q3 | 10.92 Billion JPY | 3.97% |
| 2016 FY | 109.9 Million JPY | -99.44% |
| 2016 Q4 | 12.35 Billion JPY | 13.12% |
| 2016 Q2 | 10.5 Billion JPY | -14.75% |
| 2016 Q1 | 12.32 Billion JPY | -37.27% |
| 2015 FY | 19.64 Billion JPY | 30.68% |
| 2015 Q4 | 19.64 Billion JPY | 22.2% |
| 2015 Q1 | 13.58 Billion JPY | -9.63% |
| 2015 Q2 | 9.45 Billion JPY | -30.42% |
| 2015 Q3 | 16.07 Billion JPY | 70.05% |
| 2014 Q4 | 15.03 Billion JPY | 78.25% |
| 2014 Q3 | 8.43 Billion JPY | 1.15% |
| 2014 Q2 | 8.33 Billion JPY | 4.91% |
| 2014 Q1 | 7.94 Billion JPY | -8.42% |
| 2014 FY | 15.03 Billion JPY | 73.22% |
| 2013 FY | 8.67 Billion JPY | 1.99% |
| 2013 Q3 | 6.67 Billion JPY | -11.5% |
| 2013 Q1 | 7.53 Billion JPY | -11.46% |
| 2013 Q2 | 7.54 Billion JPY | 0.16% |
| 2013 Q4 | 8.67 Billion JPY | 29.95% |
| 2012 Q4 | 8.5 Billion JPY | 16.71% |
| 2012 FY | 8.5 Billion JPY | -6.86% |
| 2012 Q3 | 7.29 Billion JPY | -14.12% |
| 2012 Q1 | 8.45 Billion JPY | -7.48% |
| 2012 Q2 | 8.49 Billion JPY | 0.44% |
| 2011 Q3 | 7.66 Billion JPY | -12.79% |
| 2011 Q4 | 9.13 Billion JPY | 19.13% |
| 2011 FY | 9.13 Billion JPY | -6.33% |
| 2011 Q1 | 8.67 Billion JPY | -11.03% |
| 2011 Q2 | 8.79 Billion JPY | 1.35% |
| 2010 Q2 | 10.26 Billion JPY | 0.0% |
| 2010 Q3 | 8.96 Billion JPY | -12.68% |
| 2010 FY | 9.75 Billion JPY | -6.54% |
| 2010 Q4 | 9.75 Billion JPY | 8.78% |
| 2009 Q4 | 10.43 Billion JPY | 8.92% |
| 2009 FY | 10.43 Billion JPY | -12.18% |
| 2009 Q3 | 9.58 Billion JPY | 0.0% |
| 2008 FY | 11.88 Billion JPY | 6.1% |
| 2007 FY | 11.2 Billion JPY | 30.9% |
| 2006 FY | 8.55 Billion JPY | -49.39% |
| 2005 FY | 16.9 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -592237.193% |
| Ansell Limited | 1.32 Billion USD | -946.615% |
| Ansell Limited | 1.33 Billion USD | -944.656% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -10917.293% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -1475664.76% |
| Psykey, Inc. | 2.47 Million USD | -562506.835% |
| ConvaTec Group Plc | 2.01 Billion USD | -589.692% |
| ConvaTec Group Plc | 2.02 Billion USD | -588.718% |
| Encision Inc. | 1.98 Million USD | -701473.816% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -457689.71% |
| Innovative MedTech Inc. | 6.13 Million USD | -226784.372% |
| LifePoint, Inc. | 2.45 Million USD | -567057.356% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -136615.45% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -409282.353% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -457713.199% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -1792825.422% |
| SmileDirectClub, Inc. | 982.26 Million USD | -1317.037% |
| Sector 10, Inc. | 9.84 Million USD | -141275.266% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -926.697% |
| SheerVision, Inc. | 1.43 Million USD | -972302.601% |
| United Health Products, Inc. | 1.99 Million USD | -696243.782% |
| Vasamed, Inc. | 1 Million USD | -1384461.822% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -366162.004% |
| Yubo International Biotech Limited | 2.91 Million USD | -477572.033% |